Tuberculosis should become a priority in the general trend towards health system reform as currently we have all leverages to change the situation with the epidemic in Ukraine for the better!

This statement was voiced by Andriy Klepikov during the press conference at UNIAN news agency held on 24 February 2017, which was aimed at discussing patient-oriented models of TB care. The executive director of Alliance also mentioned that there is a vital need to support transition to the outpatient models of TB care delivery and increase treatment efficiency. Unfortunately, today only about 40% of patients with multidrug-resistant tuberculosis are successfully cured. This indicator may be increased up to 80% and more thanks to the social support of patients so that they do not stay alone with their disease and life problems. Within its pilot projects, Alliance for Public Health proved that the combination of medical, social and psychological support allows doubling treatment success rate for patients with multidrug-resistant tuberculosis.

To sum it up, Andriy Klepikiv said that he welcomes scaling up government commitments to finance the response to tuberculosis in 2017: only budget to procure drugs will amount to half a billion hryvnias! At the same time, the most important task today is to guarantee that as compared to the previous years money will be spent for the most effective TB treatment models. From its side, Alliance as one of the key partners of the TB-REP regional project, contributes to the cooperation with all stakeholders in terms of implementation of patient-oriented approaches in response to the crisis situation with TB in Ukraine.

On behalf of the government, representative of the Ministry of Health of Ukraine, acting Head of Public Health Department, Natalia Piven thanked civil society organizations for their active involvement into the response to the TB epidemic in the country and underlined that currently efforts are underway to re-focus on evidence-based medicine and outpatient models of TB care. Piloting of those models is stipulated within the TB-REP project and is included to the concept of the National TB Program 2017-2021.

Head of TB Prevention and Treatment Unit of the Public Health Center of the Ministry of Health of Ukraine, Iana Terleieva informed that 8 thousand cases of MDR-TB are detected in Ukraine annually – in every fifth case of newly diagnosed patients and in every second case in patients with recurrent conditions. Besides, a focus was made on the main advantages of patient-oriented approaches: better treatment success rates as compared to those patients who are treated in in-patient healthcare facilities and cost efficiency due to re-allocation of funds to cover patients’ needs. Iana Terleieva underlined that it is very important to unite the efforts of governmental and non-governmental organizations!

The press-conference with participation of governmental institutions and civil society organizations was organized by Ukrainians against TB NGO within the TB-REP regional project (TB in Eastern Europe and Central Asia Project on Strengthening Health Systems for Effective TB and DR-TB Control). The Project is aimed at reforming TB care system as part of general health system reforms and provides technical support to TB projects of civil society organizations in 11 countries of Eastern Europe and Central Asia (Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan). The Project is implemented with financial support of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the principal recipient of the Project is Center for Health Policies and Studies (PAS Center).

Cornerstone decisions about the future of the TB Europe Coalition (hereinafter – TBEC) were made last week in Kyiv.

On 9-10 February 2017, Alliance had an honor to host Steering Committee strategic meeting of the TB Europe Coalition. Its participants included members of the TBEC Steering Committee, among them – civil society organizations – implementing partners of the TB-REP project and members of TBEC Secretariats – Global Health Advocates (Brussels), Results UK (London), and Alliance for Public Health (Ukraine). Welcoming speeches were delivered by Andriy Klepikov, Executive Director of Alliance for Public Health and member of the TBEC Steering Committee and by Fanny Voitzwinkler, Head of the Brussels Office of the Global Health Advocates.

The meeting was convened due to a new turn in the development of TBEC as well as new challenges and opportunities in TB response, which call for strategic decisions. The Coalition was founded in 2009 and over the years became a dynamic network of civil society organizations and activists, who join their efforts to end the epidemic of tuberculosis in Eastern Europe and Central Asia (hereinafter – EECA). TBEC develops joint initiatives with TB People, which is the first network of people with experience of TB in EECA, and the Global TB Caucus, an international movement that brings together over 1,500 parliamentarians from 130 countries of the world committed to the fight against TB.

A very important partnership for TBEC is its participation in the TB-REP project – the first regional project in the area of TB implemented in 11 EECA countries supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria (hereinafter – GF) with a component of civil society network engagement. The principal recipient of the GF grant is the Center for Health Policies and Studies (PAS Center, Moldova). TBEC together with Alliance are responsible for the support of civil society organizations within the TB-REP project. The main task in this respect is to make sure that the experience of people who were or are sick with TB are taken into account when governments are making decisions to shape people-oriented TB care.

Members of the Steering Committee and Secretariats as well as partners invited to take part in the meeting in Kyiv during the strategic planning session formulated a joint TBEC vision “World Free of Tuberculosis” and a relevant mission “Civil Society driving the TB Response”!

TBEC strategic goals for the nearest years include ensuring a strong and responsible civil society network in the area of TB response. It requires supporting the development of strategic partnerships and skills of
activists to impact the policy-making processes for effective response to TB. At the meeting, the following areas of TBEC activities up to 2020 were defined:

• Advocate for the transition to people-centered TB care,
• Participate in the transition processes to ensure sustainable response of countries to the TB epidemic after termination of the GF funding,
• Ensure access to the available TB drugs and diagnostic methods for all those who need it,
• Engage CSOs to monitoring and evaluation processes, in particular with regard to implementation of the national TB programs,
• Advocate for conducting research and developing new more effective drugs, vaccines and diagnostic methods.

Meeting participants agreed on the key priorities and further detailed steps required to achieve strategic development goals.

On 13 February 2017, Alliance for Public Health joined the One Night Stand project organized by Elena Pinchuk ANTIAIDS Foundation to mark the International Condom Day. Kyiv shopping center TsUM hosted presentation of special “safe kits” designed by Masha Bekh, comprised of bathrobes, T-shirts, condoms, and, what is most important, for the first time the “standard protection kit” also included self-tests for HIV provided by Alliance as well as information leaflets specially prepared for the campaign. Besides, during the event all visitors of the shopping center had a chance to learn about the process of HIV self-testing and receive relevant consultations.

Alliance makes a special focus on promotion of HIV self-testing as any person can test his/her fingertip blood for HIV antibodies, this process is rapid and safe and does not require other people’s assistance. Currently HIV self-testing is recommended by the World Health Organization, and rapid HIV tests may be purchased in pharmacies. On the World AIDS Day marked on 1 December 2016, Alliance for the first time handed out tests and initiated the campaign to promote HIV self-testing. To guide the process of self-testing and correctly assess test results, please consult the instruction, which can be downloaded from Alliance website, the special self-testing leaflet and the educational video.

Video from the campaign

On 6-9 February 2017, Alliance for Public Health held a four-day working meeting for partners implementing the project “Harm Reduction for Children and Young People Who Use Drugs in Ukraine” with support of the Elton John AIDS Foundation aimed at comprehensive prevention work with adolescents. Such project is implemented in Ukraine for the first time.
This project is unique because adolescents are an integral part of project team, which includes diverse specialists who are open to implementing new initiatives and demonstrate unbiased attitude to adolescents. As of today, project teams engaged over 5,000 adolescents to prevention efforts.
The working meeting held in the beginning of February 2017 was aimed at sharing the results of project activities in the field and discussing new areas, such as enrolment of adolescents from risk groups, online counseling, project supervision as well as capacity building of staff in partner organizations.
Participants of the meeting discussed successes and challenges in achieving 90-90-90 targets and key barriers in HIV testing and jointly developed ways to overcome such challenges.

One of the important program components is organizing social and medical support for adolescents who use drugs. The participants reviewed scheme of the work of social and medical support teams, criteria of client enrolment into the support program and practical cases, with which local teams face.

“The meeting allowed to once more discuss the issues arising in the course of project implementation, I learned a lot of new and important things concerning first contact with adolescents.”
Anatolii, project coordinator, Our Help NGO (Sloviansk)

“It really helps that our work is structured and we are supported by our partners in solving difficult situations. We like it that we can use the wide range of forms and tools in working with this target group.”
Iryna, psychologist, The Way Home NGO (Odesa)

On 3 February 2017, Alliance for Public Health officially presented the project “Fast-track TB/HIV responses for key populations in EECA cities” supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria. Ukraine will be represented in this project by Odesa, where the regional project was announced today. The goal of the project is to develop sustainable response to the HIV/TB epidemics in key populations at the level of Odesa, which will significantly contribute to achieving the 90-90-90 targets in key populations. Gennadiy Trukhanov, the mayor of Odesa, assured that he supports the initiative and is ready for future cooperation. It is expected that the project will help to enhance the dynamics towards reducing AIDS and TB mortality in Odesa and ensure sustainable response to the epidemics at the city level.  Launch of the project was announced at the meeting of a wide range of civil society organizations and relevant agencies of the city chaired by the mayor. Andriy Klepikov, executive director of Alliance, expressed his sincere gratitude to the city administration for their commitment to improving the health of Odesa residents. He said, “We hope that such attitude will both set the tone for this regional initiative and will become an example for the mayors of other Ukrainian cities”.

On 26 January 2017, the Ministry of Health of Ukraine hosted the first meeting of the Coordinating Group on Implementing Activities to Reform the Healthcare System in the Area of TB Response. This first session of the Coordinating Group chaired by the Deputy Minister of Health, Oksana Syvak, was attended by partners representing government and civil society as well as representatives of the WHO Regional Office for Europe and the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Coordinating Group will include representatives of the Alliance: Sergiy Filippovych, Director: Treatment, Procurement and Supply Management and Yulia Chorna, Project Manager: TB Advocacy.

The group was created in order to elaborate and implement an action plan on the TB care reform in Ukraine. An important aspect of this reform is support of patient-oriented treatment of TB patients using outpatient care models. The specific objectives, which should be resolved by the government in the course of reforming the TB care, are related to capacity building and management of human resources as well as improving the effectiveness of funding in the delivery of TB care. The state, guided by the Ministry of Health, demonstrates its commitment to the reform by supporting the high-level national coordinating group.

The priority in providing support to TB patients is a focus on outpatient services. New funding models will be implemented based on the results of activities in this area. As for the resulting resources, they will be reinvested to support TB response interventions at the outpatient stage. As part of the new model of health care for TB patients, the required mechanisms of social contracting will be developed to supply TB services, in particular in the context of working with key populations.

The national coordinating group was created within the regional TB-REP project (TB in Eastern Europe and Central Asia Project on Strengthening Health Systems for Effective TB and DR-TB Control), with Alliance for Public Health being partner of this Project on behalf of TB Europe Coalition. The project is aimed at reforming the TB care system as part of the general health care reforms and is implemented in 2016-2018 with financial support of the Global Fund in 11 countries of Eastern Europe and Central Asia (Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan). Principal Recipient of the Global Fund grant is the Center for Health Policies and Studies (PAS Center), with technical leadership of the WHO Regional Office for Europe.

The general goal of the project is to reduce the TB burden and to halt the spread of drug-resistant TB by ensuring political commitment and extensive use of evidence-based patient-oriented approaches in the delivery of TB prevention, care and treatment services. An important approach of the project is joining efforts at different levels – from the state to the civil society – to provide more effective TB care. TB Europe Coalition together with the Alliance for Public Health is responsible for the component of supporting advocacy efforts from the side of civil society organizations implementing the project in 11 countries. Civil society partner of the Project in Ukraine is CO “The Ukrainians against TB”. The main advocacy efforts of civil society organizations are aimed at supporting the transition to patient-oriented models of TB care with a focus on providing such care in outpatient settings.

Intensive discussions, which have been taking place in the recent week, while negotiating various approaches to the preparation and submission of the next request to the Global Fund for the period of 2018-2020, led to consolidation of the key positions of all three Principal Recipients of the current GF grant.

Key outcomes of the dialogue:

• Agreeing on the option of submitting the new funding request on HIV/TB in a form of full application by 20 May 2017 based on the principles of transparency with full inclusiveness of all communities affected with the epidemics of HIV and tuberculosis and civil society organizations. The main programmatic priorities of the new request should be achievement of the 90-90-90-90 targets.
• Receiving clear guarantees of ensuring state funding to provide treatment and prevention services to key populations. In the new request, the government should demonstrate how it will ensure gradual transition to full state funding of all programs from the national budget till
• Recognizing the role of civil society at all stages, including its role in governance, management and implementation structure of the future program. Taking into account that USD 60 mln (50% of the total funding) will be designated for key populations, the parties agreed on dedicated funding to develop capacity of the communities affected with the epidemics of HIV and tuberculosis.

The joint statement (attached) was signed by the heads of the Alliance for Public Health, Public Health Center of the Ministry of Health of Ukraine and the All-Ukrainian Network of People Living with HIV.

THE JOINT STATEMENT

Currently most effective directly-acting antiviral agent for hepatitis C (HCV) treatment has already arrived to Ukraine! Alliance for Public Health launches the third phase of HCV treatment program for key populations. This phase stipulates using a direct-acting antiviral agent, which is new for Ukraine – Harvoni (sofosbuvir/ledipasvir) – as well as continuing using sofosbuvir-based regimens. Those drugs are highly effective and demonstrate much fewer side effects as compared to the traditional pegylated interferon-based regimens. According to WHO, at least 94% of patients can be cured with such drugs (treatment success rate may be up to 100%) (http://www.who.int/hepatitis/news-events/hepatitis-c-guidelines-2016-story/en/). Both drugs are recommended by WHO for hepatitis C treatment  (Guidelines for the Screening, Care and Treatment of Persons with Chronic Hepatitis C Infection http://apps.who.int/iris/bitstream/10665/205035/1/9789241549615_eng.pdf?ua=1), as well as the national guidelines (Unified Clinical Protocol of Primary, Secondary (Specialized), and Tertiary (Highly Specialized) Medical Aid “Viral Hepatitis C in Adults” ).

Within the third phase of the Program, Alliance plans to provide free access to innovative HCV treatment to 750 patients – members of key populations and military troops taking part in the armed conflict in the east of Ukraine. Drugs for 500 treatment courses, which are already at the warehouse of Alliance, have been donated.

Treatment will be delivered in 21 healthcare facilities (20 state-run institutions and 1 private clinic) in 15 regions of Ukraine. In total, starting from June 2015, treatment was provided in 25 healthcare facilities in 19 regions of Ukraine. Alliance is considering a possibility of further program expansion. For the first time, the list of healthcare institutions will include the Main Military Hospital with a special quota for the military servicemen (20 treatment courses).

In the beginning of February, Alliance will organize training for the medical doctors who will prescribe new regimens in line with the WHO guidelines and the updated national protocol of HCV treatment.

As of 1 January 2017, access to treatment within the Alliance hepatitis C treatment program was provided to 1,207 patients representing key populations, 78% of whom are HIV-positive. Treatment success rate among the patients, who already had their follow-up tests 12 weeks after treatment completion, is 94%.

Alliance also makes all the efforts to ensure inclusion of Harvoni and other essential direct-acting antivirals to the national list of essential medicines to be procured with national and local budget funds. Unfortunately, the draft list published at the website of the Ministry of Health does not contain any of the direct-acting antivirals, which have been procured by Alliance for over two years.

Healthcare facilities to implement the third phase of the program

on the Status of HIV/TB/HCV Prevention and Treatment and OST Programs in Donetsk and Luhansk oblasts
(as of 23 January 2017)

Alliance for Public Health with support of the Global Fund to Fight AIDS, Tuberculosis and Malaria launches a new pilot project “Result-Based Financing (RBF) for DOT Provision to TB Patients at the Ambulatory Phase”. The main aim of this project is to pilot new ambulatory treatment financing models to focus healthcare professionals on the results: bringing down the number of drop-outs and improving treatment success rates. Such approach will surely contribute to a higher transparency in funds utilization and will allow identifying challenges in directly-observed treatment (DOT) of tuberculosis. Involving primary health care institutions is equally important as it will be a good incentive for medical personnel of such institutions.

On 22–23 December 2016, presentation of this project was held in Odesa attended by chief physicians of primary health care centers, district TB treatment doctors and leading specialists of the Odesa regional TB treatment center. The participants discussed the prerequisites of transition to ambulatory TB treatment models, challenges existing in the region and the ways to overcome them.

The project will be implemented in 2017 in 14 districts of Odesa oblast. Districts to implement the pilot project were selected based on the high TB prevalence, the need to considerably improve the existing treatment success rates for patients with sensitive TB and multidrug-resistant TB (hereinafter – MDR-TB) and, at the same time, high commitment of the regional administration to fighting the TB epidemic, implementation of new projects, cooperation with international and non-governmental organizations and readiness of primary health care institutions to take upon the functions of directly-observed treatment of TB patients at the ambulatory phase.

The results of this pilot project may form a solid basis for the general strategy of ensuring sustainability of TB programs, contributing to the achievement of the goals set forth in the Global Plan to End TB.

Within this project, health care institutions will provide directly-observed ambulatory TB treatment within any format of care (DOT offices at TB treatment centers or primary health care institutions, home care, day care, etc.), keeping relevant records.

For the goals of this project, 380 patients with both sensitive and drug-resistant TB will be enrolled in treatment. This pilot project stipulates a new way of financing ambulatory DOT. Implementing partners will receive financing for each ambulatory patient, which will contribute to increasing treatment success rates (treatment completion with such results as “cured” or “treatment completed”) and working with patients to form adherence to treatment (the higher the adherence of a patient, the less funds are to be spent to retain such patient in treatment). If target indicators are met, incentive bonuses will be paid, which health care institutions will be free to spend at their own discretion within certain limits, which will boost their interest in this project.